Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Comment by wesdevrieson Jul 05, 2011 5:32pm

302 Views

Post# 18798381

RE: RE: Kane valuation breakdown

My best guess is that they would be a buy-out target; but that is all it is, a guess. For now, there is not one analyst out there that I know of giving this stock even a speculative buy right now, but that is not to say; that they are not watching Kane! Coverage can come very fast and the dynamics can change very quickly for KNE; this makes this stock very exciting! IMO
Good Luck!
wdv

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario